|
Statement
| 1.Date of the board of directors resolution:2022/07/28
2.Source of capital increase funds:
Capital raising through issuance of common shares
3.Whether to adopt shelf registration (Yes, please state issuance period/No):
No
4.Total monetary value of the issuance and number of shares issued (shares
issued not including those distributed to employees if consisting in
capital increase from earnings or capital surplus):N/A
5.If adopting shelf registration, monetary value and number of shares
to be issued this time:N/A
6.The remaining monetary value and shares after this issuance when
adopting shelf registration:N/A
7.Par value per share:NT$10
8.Issue price:The actual issue price of capital raising shall be adjusted
due to market conditions, in accordance with Article 6 of "Self-regulation
Measures for Under-writers Providing Guidance to Companies in Raising and
Issuing Marketable Securities" of the Taiwan Securities Association.
9.Number of shares subscribed for by or allocated to employees:
10% of newly issued common shares, translating to 37,000,000 shares
10.Number of shares publicly sold:
10% of newly issued common shares, translating to 37,000,000 shares
11.Ratio of shares subscribed by or allotted as stock dividends to existing
shareholders:
80% of newly issued common shares, translating to 296,000,000 shares
12.Handling method for fractional shares and shares unsubscripted for by
the deadline:
The Chairman with the authorization from the Board will
allocate uncombined shares, fractional shares, or unsubscribed shares
by existing shareholders and employees to specific persons at the issue
price.
13.Rights and obligations of these newly issued shares:
Rights and obligations of the newly issued shares are equal to
existing shares.
14.Utilization of the funds from the capital increase:
To repay bank loans.
15.Any other matters that need to be specified:
The Chairman is authorized by the Board to decide issue price within the
authorized indicative range, number of shares issued, issue terms, schedule
of the planned use of funds, estimated potential benefits, and other related
matters of the capital raising plan.
|
